Product Code: 2912
The biomedical warming and thawing devices market is projected to witness substantial growth by 2027 primarily driven by the soaring demand for blood and plasma transfusions across the globe. Moreover, growing consumer interest in cryopreservation is expected to further impel market expansion over the forecast period.
Recently, to monetize on the booming market demand in key regions, companies have been focusing on product development and innovation, thereby fostering industry outlook. For instance, in January 2020, FreMon Scientific, a US-based medical equipment provider, announced that its ZipThaw device was granted FDA clearance as a Class II medical device for frozen plasma thawing.
ZipThaw, the first dry & portable precision plasma thawing device in the world, is utilized in conjunction with the ZipSleeve anti-contaminant disposable barrier and enables clinicians to provide patients with plasma in time and at the right temperature. The device requires virtually no maintenance, ensures that the thawing is accurately measured, and makes end-to-end thawing process easy to handle with fewer technical personnel.
For comprehensive assessment, the biomedical warming and thawing devices market has been categorized based on product, sample, end-use, and region. In terms of product, the market has been segmented into automatic and manual.
In 2020, the automatic sub-segment held a considerable revenue share in the biomedical warming and thawing devices market and is estimated to reach a valuation of around USD 105 million by 2027. Mounting preference for automated systems, along with numerous advantages offered by automated thawing devices, is likely to boost segmental adoption over the following years.
With respect to sample, the market has been divided into ovum/embryo, semen, blood products, and others. The blood products sub-segment was valued at over USD 83 million in 2020 and is projected to expand at a steady pace over 2021-2027. Increasing occurrences of accidental deaths and injuries causing severe bleeding and blood loss are anticipated to fuel segmental growth in the coming years.
From the end-use perspective, the market has been segregated into blood banks and transfusion centers, research laboratories, hospitals, pharmaceutical industry, and others. In 2020, the blood banks and transfusion centers sub-segment accounted for more than 32% of the biomedical warming and thawing devices market and is speculated to progress at a steady CAGR over the analysis period. National policies promoting donation of blood and plasma have led to an increase in the number of blood banks & transfusion centers across the globe, which is slated to foster segmental outlook in the future.
On the regional spectrum, the Middle East & Africa biomedical warming and thawing devices market was valued at approximately USD 12 million in 2020 and is expected to observe robust growth through the study timeframe. Growing usage of cryopreserved products across various countries in the region is set to propel market expansion over the forecast timeline.
Table of Contents
Chapter 1 Methodology
- 1.1 Market definition
- 1.2 Base estimates & working
- 1.3 Forecast parameters
- 1.4 Data validation
- 1.5 Data sources
- 1.5.1 Secondary
- 1.5.1.1 Paid sources
- 1.5.1.2 Unpaid sources
- 1.5.2 Primary
Chapter 2 Executive Summary
- 2.1 Biomedical warming and thawing devices industry 360 degree synopsis, 2016 - 2027
- 2.1.1 Business trends
- 2.1.2 Product trends
- 2.1.3 Sample trends
- 2.1.4 End-use trends
- 2.1.5 Regional trends
Chapter 3 Biomedical Warming and Thawing Devices Industry Insights
- 3.1 Industry segmentation
- 3.2 Industry landscape, 2016 - 2027 (USD Million)
- 3.3 Industry impact factors
- 3.3.1 Growth drivers
- 3.3.1.1 Growing number of blood banks and blood infusion centers worldwide
- 3.3.1.2 Increased development of sample analysis and studies in the biotechnology sector
- 3.3.1.3 Increasing number of road accidents and trauma cases leading to blood transfusions
- 3.3.2 Industry pitfalls & challenges
- 3.3.2.1 Strict regulations related to thawed biomedical products and samples
- 3.3.2.2 Issues related to large batch size
- 3.4 Growth potential analysis
- 3.4.1 By product
- 3.4.2 By sample
- 3.4.3 By end-use
- 3.5 COVID-19 impact analysis
- 3.6 Porter's analysis
- 3.7 Competitive landscape, 2020
- 3.7.1 Company matrix analysis, 2020
- 3.8 PESTEL analysis
Chapter 4 Biomedical Warming and Thawing Devices Market, By Product
- 4.1 Key segment trends
- 4.2 Manual
- 4.2.1 Market size, by region, 2016 - 2027 (USD Million)
- 4.3 Automatic
- 4.3.1 Market size, by region, 2016 - 2027 (USD Million)
Chapter 5 Biomedical Warming and Thawing Devices Market, By Sample
- 5.1 Key segment trends
- 5.2 Blood products
- 5.2.1 Market size, by region, 2016 - 2027 (USD Million)
- 5.3 Ovum/embryo
- 5.3.1 Market size, by region, 2016 - 2027 (USD Million)
- 5.4 Semen
- 5.4.1 Market size, by region, 2016 - 2027 (USD Million)
- 5.5 Others
- 5.5.1 Market size, by region, 2016 - 2027 (USD Million)
Chapter 6 Biomedical Warming and Thawing Devices Market, By End-use
- 6.1 Key segment trends
- 6.2 Hospitals
- 6.2.1 Market size, by region, 2016 - 2027 (USD Million)
- 6.3 Research laboratories
- 6.3.1 Market size, by region, 2016 - 2027 (USD Million)
- 6.4 Pharmaceutical industry
- 6.4.1 Market size, by region, 2016 - 2027 (USD Million)
- 6.5 Blood banks and transfusion centers
- 6.5.1 Market size, by region, 2016 - 2027 (USD Million)
- 6.6 Others
- 6.6.1 Market size, by region, 2016 - 2027 (USD Million)
Chapter 7 Biomedical warming and thawing Devices Market, By Region
- 7.1 Key regional trends
- 7.2 North America
- 7.2.1 Market size, by country, 2016 - 2027 (USD Million)
- 7.2.2 Market size, by product, 2016 - 2027 (USD Million)
- 7.2.3 Market size, by sample, 2016 - 2027 (USD Million)
- 7.2.4 Market size, by end-use, 2016 - 2027 (USD Million)
- 7.2.5 U.S.
- 7.2.5.1 Market size, by product, 2016 - 2027 (USD Million)
- 7.2.5.2 Market size, by sample, 2016 - 2027 (USD Million)
- 7.2.5.3 Market size, by end-use, 2016 - 2027 (USD Million)
- 7.2.6 Canada
- 7.2.6.1 Market size, by product, 2016 - 2027 (USD Million)
- 7.2.6.2 Market size, by sample, 2016 - 2027 (USD Million)
- 7.2.6.3 Market size, by end-use, 2016 - 2027 (USD Million)
- 7.3 Europe
- 7.3.1 Market size, by country, 2016 - 2027 (USD Million)
- 7.3.2 Market size, by product, 2016 - 2027 (USD Million)
- 7.3.3 Market size, by sample, 2016 - 2027 (USD Million)
- 7.3.4 Market size, by end-use, 2016 - 2027 (USD Million)
- 7.3.5 Germany
- 7.3.5.1 Market size, by product, 2016 - 2027 (USD Million)
- 7.3.5.2 Market size, by sample, 2016 - 2027 (USD Million)
- 7.3.5.3 Market size, by end-use, 2016 - 2027 (USD Million)
- 7.3.6 France
- 7.3.6.1 Market size, by product, 2016 - 2027 (USD Million)
- 7.3.6.2 Market size, by sample, 2016 - 2027 (USD Million)
- 7.3.6.3 Market size, by end-use, 2016 - 2027 (USD Million)
- 7.3.7 UK
- 7.3.7.1 Market size, by product, 2016 - 2027 (USD Million)
- 7.3.7.2 Market size, by sample, 2016 - 2027 (USD Million)
- 7.3.7.3 Market size, by end-use, 2016 - 2027 (USD Million)
- 7.3.8 Spain
- 7.3.8.1 Market size, by product, 2016 - 2027 (USD Million)
- 7.3.8.2 Market size, by sample, 2016 - 2027 (USD Million)
- 7.3.8.3 Market size, by end-use, 2016 - 2027 (USD Million)
- 7.3.9 Italy
- 7.3.9.1 Market size, by product, 2016 - 2027 (USD Million)
- 7.3.9.2 Market size, by sample, 2016 - 2027 (USD Million)
- 7.3.9.3 Market size, by end-use, 2016 - 2027 (USD Million)
- 7.4 Asia Pacific
- 7.4.1 Market size, by country, 2016 - 2027 (USD Million)
- 7.4.2 Market size, by product, 2016 - 2027 (USD Million)
- 7.4.3 Market size, by sample, 2016 - 2027 (USD Million)
- 7.4.4 Market size, by end-use, 2016 - 2027 (USD Million)
- 7.4.5 China
- 7.4.5.1 Market size, by product, 2016 - 2027 (USD Million)
- 7.4.5.2 Market size, by sample, 2016 - 2027 (USD Million)
- 7.4.5.3 Market size, by end-use, 2016 - 2027 (USD Million)
- 7.4.6 Japan
- 7.4.6.1 Market size, by product, 2016 - 2027 (USD Million)
- 7.4.6.2 Market size, by sample, 2016 - 2027 (USD Million)
- 7.4.6.3 Market size, by end-use, 2016 - 2027 (USD Million)
- 7.4.7 India
- 7.4.7.1 Market size, by product, 2016 - 2027 (USD Million)
- 7.4.7.2 Market size, by sample, 2016 - 2027 (USD Million)
- 7.4.7.3 Market size, by end-use, 2016 - 2027 (USD Million)
- 7.4.8 Australia
- 7.4.8.1 Market size, by product, 2016 - 2027 (USD Million)
- 7.4.8.2 Market size, by sample, 2016 - 2027 (USD Million)
- 7.4.8.3 Market size, by end-use, 2016 - 2027 (USD Million)
- 7.4.9 South Korea
- 7.4.9.1 Market size, by product, 2016 - 2027 (USD Million)
- 7.4.9.2 Market size, by sample, 2016 - 2027 (USD Million)
- 7.4.9.3 Market size, by end-use, 2016 - 2027 (USD Million)
- 7.5 Latin America
- 7.5.1 Market size, by country, 2016 - 2027 (USD Million)
- 7.5.2 Market size, by product, 2016 - 2027 (USD Million)
- 7.5.3 Market size, by sample, 2016 - 2027 (USD Million)
- 7.5.4 Market size, by end-use, 2016 - 2027 (USD Million)
- 7.5.5 Brazil
- 7.5.5.1 Market size, by product, 2016 - 2027 (USD Million)
- 7.5.5.2 Market size, by sample, 2016 - 2027 (USD Million)
- 7.5.5.3 Market size, by end-use, 2016 - 2027 (USD Million)
- 7.5.6 Mexico
- 7.5.6.1 Market size, by product, 2016 - 2027 (USD Million)
- 7.5.6.2 Market size, by sample, 2016 - 2027 (USD Million)
- 7.5.6.3 Market size, by end-use, 2016 - 2027 (USD Million)
- 7.5.7 Argentina
- 7.5.7.1 Market size, by product, 2016 - 2027 (USD Million)
- 7.5.7.2 Market size, by sample, 2016 - 2027 (USD Million)
- 7.5.7.3 Market size, by end-use, 2016 - 2027 (USD Million)
- 7.6 Middle East and Africa
- 7.6.1 Market size, by country, 2016 - 2027 (USD Million)
- 7.6.2 Market size, by product, 2016 - 2027 (USD Million)
- 7.6.3 Market size, by sample, 2016 - 2027 (USD Million)
- 7.6.4 Market size, by end-use, 2016 - 2027 (USD Million)
- 7.6.5 South Africa
- 7.6.5.1 Market size, by product, 2016 - 2027 (USD Million)
- 7.6.5.2 Market size, by sample, 2016 - 2027 (USD Million)
- 7.6.5.3 Market size, by end-use, 2016 - 2027 (USD Million)
- 7.6.6 Saudi Arabia
- 7.6.6.1 Market size, by product, 2016 - 2027 (USD Million)
- 7.6.6.2 Market size, by sample, 2016 - 2027 (USD Million)
- 7.6.6.3 Market size, by end-use, 2016 - 2027 (USD Million)
- 7.6.7 UAE
- 7.6.7.1 Market size, by product, 2016 - 2027 (USD Million)
- 7.6.7.2 Market size, by sample, 2016 - 2027 (USD Million)
- 7.6.7.3 Market size, by end-use, 2016 - 2027 (USD Million)
- 7.6.8 Iran
- 7.6.8.1 Market size, by product, 2016 - 2027 (USD Million)
- 7.6.8.2 Market size, by sample, 2016 - 2027 (USD Million)
- 7.6.8.3 Market size, by end-use, 2016 - 2027 (USD Million)
Chapter 8 Company Profiles
- 8.1 Competitive dashboard, 2020
- 8.2 Helmer Scientific
- 8.2.1 Business overview
- 8.2.2 Financial data
- 8.2.3 Product landscape
- 8.2.4 Strategic outlook
- 8.2.5 SWOT analysis
- 8.3 Brooks Life Sciences
- 8.3.1 Business overview
- 8.3.2 Financial data
- 8.3.3 Product landscape
- 8.3.4 Strategic outlook
- 8.3.5 SWOT analysis
- 8.4 Sartorius AG
- 8.4.1 Business overview
- 8.4.2 Financial data
- 8.4.3 Product landscape
- 8.4.4 Strategic outlook
- 8.4.5 SWOT analysis
- 8.5 Sarstedt AG & Co. KG
- 8.5.1 Business overview
- 8.5.2 Financial data
- 8.5.3 Product landscape
- 8.5.4 Strategic outlook
- 8.5.5 SWOT analysis
- 8.6 Boekel Scientific
- 8.6.1 Business overview
- 8.6.2 Financial data
- 8.6.3 Product landscape
- 8.6.4 Strategic outlook
- 8.6.5 SWOT analysis
- 8.7 Barkey
- 8.7.1 Business overview
- 8.7.2 Financial data
- 8.7.3 Product landscape
- 8.7.4 Strategic outlook
- 8.7.5 SWOT analysis
- 8.8 Labtop Instruments Pvt. Ltd.
- 8.8.1 Business overview
- 8.8.2 Financial data
- 8.8.3 Product landscape
- 8.8.4 Strategic outlook
- 8.8.5 SWOT analysis
- 8.9 Cardinal Health, Inc.
- 8.9.1 Business overview
- 8.9.2 Financial data
- 8.9.3 Product landscape
- 8.9.4 Strategic outlook
- 8.9.5 SWOT analysis
- 8.10 Cytiva
- 8.10.1 Business overview
- 8.10.2 Financial data
- 8.10.3 Product landscape
- 8.10.4 Strategic outlook
- 8.10.5 SWOT analysis
- 8.11 BioLife Solutions
- 8.11.1 Business overview
- 8.11.2 Financial data
- 8.11.3 Product landscape
- 8.11.4 Strategic outlook
- 8.11.5 SWOT analysis